Koninklijke Philips NV (PHIA) Given a €35.00 Price Target by J P Morgan Chase & Co Analysts
Koninklijke Philips NV (AMS:PHIA) has been assigned a €35.00 ($38.89) price objective by investment analysts at J P Morgan Chase & Co in a research note issued on Monday. The brokerage currently has a “buy” rating on the stock.
Several other analysts also recently weighed in on the company. Kepler Capital Markets set a €36.00 ($40.00) price objective on Koninklijke Philips NV and gave the company a “buy” rating in a research report on Friday, June 2nd. Morgan Stanley set a €27.50 ($30.56) price objective on Koninklijke Philips NV and gave the company a “neutral” rating in a research report on Tuesday, May 23rd.
Shares of Koninklijke Philips NV (AMS:PHIA) traded up 6.448% on Monday, reaching €33.925. 6,927,004 shares of the company were exchanged. The stock’s 50-day moving average is €31.99 and its 200 day moving average is €29.49. The firm has a market capitalization of €31.22 billion and a PE ratio of 19.123. Koninklijke Philips NV has a 12-month low of €20.90 and a 12-month high of €34.02.
TRADEMARK VIOLATION NOTICE: “Koninklijke Philips NV (PHIA) Given a €35.00 Price Target by J P Morgan Chase & Co Analysts” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/06/19/koninklijke-philips-nv-phia-given-a-35-00-price-target-by-j-p-morgan-chase-co-analysts.html.
Koninklijke Philips NV Company Profile
Koninklijke Philips N.V. is a health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, and Lighting. The Company’s Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Receive News & Ratings for Koninklijke Philips NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips NV and related companies with MarketBeat.com's FREE daily email newsletter.